Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis. [electronic resource]
- Journal of neurology, neurosurgery, and psychiatry Mar 2017
- 196-203 p. digital
Publication Type: Journal Article; Observational Study
1468-330X
10.1136/jnnp-2016-313976 doi
Cohort Studies Disability Evaluation Persons with Disabilities Disease Progression Female Humans Immunomodulation--immunology Male Multiple Sclerosis, Relapsing-Remitting--drug therapy